Research into idiopathic pulmonary fibrosis (IPF) has been rapidly gathering pace over the
past few years. This has been driven by a number of important factors, including the …

… NCT02632123 “Validation of the risk stratification score in idiopathic pulmonary fibrosis”. …
(% predicted) to stratify patients in 3 different stages of the disease. This model was validated …

… idiopathic pulmonary fibrosis (IPF) is defined as a sudden acceleration of the disease with the
appearance of pulmonary … differences according to clinical stratification (AE, suspected AE, …

… enrich or stratify a study population with patients at increased risk of events indicative of
disease … over 14 weeks is not apparently useful for stratification or enrichment. Here, more rapid …

… Idiopathic pulmonary fibrosis (IPF), also referred to as cryptogenic fibrosing alveolitis, is a
progressive interstitial lung disease … Our classification scheme for IPF is easily and consistently …

… The most widely replicated variant (rs35705950) is located in the promoter region of the
MUC5B gene and has been strongly associated with idiopathic pulmonary fibrosis (IPF) and …

… course of the disease and the identification of biomarkers of progression would lead to a
better stratification of the disease, essential for delivering individualized therapeutic strategies. …

… In fact, major collinearity of VRS with the CALIPER-total volume of lung fibrosis was … for
stratification of outcome: we found that the relative change of total volume of lung fibrosis best fits …

… Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive fibrosing
interstitial pneumonia of unknown causes. Current diagnostic criteria are based on radiological, …

… There is a lack of prognostic biomarkers in idiopathic pulmonary fibrosis (IPF) patients. The
objective of this study is to investigate the potential of 18 F-FDG-PET/ CT to predict mortality …